Clinical trial Recruiting at 1 site Interventional Ages 60 and up

Improving physical and mental ability to keep older adults independent in Singapore

Official title: Optimizing INtrinsic Capacity for Functional INdependence and to Impede FrailTY in Older Adults: Adaptation of the WHO-ICOPE for Healthy Ageing in Singapore

Run by Sengkang General Hospital · NCT07477561 · Data updated 2026-11-12

This program will test whether regular combined screening and targeted care using apps and clinical referrals helps Singaporean adults aged 60+ stay independent and slow frailty.

Quick facts

Study typeInterventional
Ages60 Years and up
SexAll
Enrollment600 (estimated)
SponsorSengkang General Hospital
Academic / other
Locations1 site (Singapore)
StatusRecruiting
StartedJuly 17, 2023
Main results expectedJune 30, 2027
Study endsJanuary 15, 2028
Registry record updatedApril 17, 2026
Trial IDNCT07477561 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Community-dwelling Singapore citizens or permanent residents aged 60 or older who can provide informed consent and are able to participate in app-based and clinic-based components are ideal candidates.

Probably not a fit

Residents of sheltered or nursing homes, non-Singaporeans, those under 60, or people unable to consent or engage with remote tools are unlikely to benefit from this community-focused program.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The program combines routine screening for frailty and intrinsic capacity with a tiered care pathway that offers technology-assisted self-screening, remote monitoring, behavioural nudges, and clinical referrals for those with identified needs. It uses tools such as the SCREENii algorithm for objective frailty assessment and the ENGAGE app for ongoing self-monitoring and engagement. Participants are randomized to immediate intervention or a wait-list control and outcomes are tracked primarily by changes in life-space mobility, with secondary measures including screening uptake, adherence to care pathways, quality of life, and implementation sustainability. The study also includes preparatory phases to establish technology readiness, care pathways, and community partnerships to support scale-up.

Why it matters

Potential benefit: If successful, the program could help older adults maintain independence, reduce functional decline, and improve quality of life through earlier detection and timely support.

How similar studies have gone: Previous multicomponent frailty and WHO-ICOPE–based programs have shown promising but mixed results, and technology-enabled community delivery represents a relatively new and less-tested approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria: (in Phases 1, 2 and 3):

* Any Singaporean or Permanent Resident (PR) aged 60 years and above
* Able to provide informed consent (or legally acceptable representative available)

Exclusion Criteria (in Phases 1, 2 and 3):

* Non-Singaporeans or non-PRs under 60 years of age
* Residents of sheltered or nursing homes

Where it's running

  • Sengkang General Hospital
    Singapore, Singapore
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.